Chapter 340 Vegetative State

Chapter 340 Vegetative State

Chapter 340 Vegetative State

September.

Typhoon No. 8 this year and also the third super typhoon this year, Pineapple directly hit Shanmei.

Amid the storm, many durian plantations suffered heavy losses, with more than 8,000 acres of durian completely destroyed and more than half of 20,000 acres lost.

However, there have been no widespread complaints about this situation in the local area. This is mainly because a large part of the durian plantations in Shanmei are directly operated by Hailufeng Company, and the remaining individual growers have also accumulated a lot of capital in recent years.

Plus there is the risk of purchasing a unit every year.

Although the losses were heavy, we could still hold on.

Especially for the wealthy Hailufeng Company, the loss of just tens of thousands of acres of durian is really a drop in the bucket.

After all, Hailufeng Company has invested in large-scale durian plantations in Siam, Malaysia and Java. Since the domestic production area has reduced production due to the typhoon disaster, it can be made up from the Southeast Asian production areas.

What's more, Qiongzhou's durian industry is also very large.

Therefore, even if there are problems in the Shanmei durian production area, the domestic durian price remains as stable as ever. The retail price of the Golden Pillow durian and last year's newly modified Tomani durian remains at around 15 yuan per kilogram.

Jiang Miao was not at the Shanmei headquarters.

But it is the neighboring Jiexi County.

One side of the indoor agricultural base in Jiexi County.

Jiang Miao listened to the roaring storm outside the window, but he was not worried about anything. He was still concentrating on looking at some information.

"Boss." Ah Hai, the head of scientific research at the base, walked in.

"What's the result?" Jiang Miao asked without raising his head.

Ah Hai smiled and said, "The animal experiment was very good. The effect of artificial blood is almost the same as that of human blood. It can even be said that the effect is better."

Jiang Miao took the animal experiment report, looked through it carefully, and asked, "Then continue to increase the scale of animal experiments and strive to conduct another 2,000 animal experiments within two months."

"No problem." Ah Hai made note of this.

Artificial blood technology is another derivative of non-rejection organ technology.

Jiang Miao used umbrella sugarcane as the mother plant and carried out genetic modification again to create blood sugarcane that can synthesize human blood.

However, its production efficiency is not high, because after the photosynthesis modification, it will also affect the synthesis of red blood cells, platelets and other products, so its genes have to be adjusted.

At present, each acre of blood sugarcane can produce about 30 liters of artificial whole blood every day, about 900 liters every month, and about 10 tons of whole blood per acre every year.

These artificial bloods have four main blood types: A, B, AB, and O, as well as a small number of other panda blood types, all of which can be mass-produced.

Perhaps in the near future, artificial blood will be produced in indoor plantations like cane sugar, and then supplied to various medical institutions within the Asian Union.

Compared to dangerous and troublesome human blood, artificial blood has huge advantages.

The supply of raw human blood is unstable and may carry various viruses and bacteria. For example, Amerika, the world's largest exporter of blood products, has been exposed to produce blood products that contain viruses such as HIV.
However, the domestic supply of raw human blood is facing the problem of a decrease in the number of blood donors.

The company runs the Hailufeng Hospital. Jiang Miao has naturally read the internal reports of the Hailufeng Hospital. There is a huge gap in blood-related treatments. Although the patients' families can donate blood, there are still a lot of troublesome problems.

For example, the physical health of blood donors has become a huge limitation for blood donation.

Why does Ah Hai say that artificial blood is better than human blood? It is because artificial blood is safer. At least there is no need to worry about the possibility of blood being contaminated by HIV.

Moreover, even if the blood donor does not have infectious diseases such as hepatitis B or AIDS, the health of his blood is also an indicator that needs to be considered.

For example, many young people in China now suffer from high blood lipids and high blood sugar, and blood stations generally do not accept this kind of blood.

Artificial blood does not have this problem.

The blood cane gene specially customized by Jiang Miao can accurately regulate the components of artificial blood, allowing blood to be produced with the healthiest composition ratio.

Secondary refined products such as plasma, platelets, immunoglobulins, human serum albumin, etc. can also be refined using artificial blood.

This industry is very important.

Especially for the Asian Union, where the aging population is becoming increasingly serious, we certainly cannot count on the elderly to donate blood. In addition, some of them have illnesses and cannot donate blood either. Relying on the dwindling number of young people to donate blood is not a long-term solution after all.

As for opening up imports, this is a very good idea, but forget about it.

It’s not that there are no sources of imports.

Rather, the risks of external blood products are too high.

The toxic blood of America caused many people in the European Union to be infected with AIDS due to blood transfusions.

Even if we do not import blood products from America, blood products from other regions still pose huge risks.

For example, in South Asia, which is still in the late Ming Dynasty theater version, if Seris said that he wanted to import 10,000 tons of blood products from there, it is estimated that various local forces would find ways to capture people and squeeze their blood.

But can this blood be used?
Unless every bag of blood is thoroughly tested, there is no way to guarantee the safety of blood products.

Every package of blood products can be extensively tested, which can quickly drive up costs.

In addition, the shelf life of blood is relatively short and the storage conditions are relatively harsh, which will increase the overall cost.

This practical limitation has also led to endless debate and relative conservatism in China in recent years on the issue of expanding the scale of blood product imports.

Seris would rather invest in genetically modified rice to produce human albumin than expand imports of foreign blood products because of concerns about safety issues.

Based on this situation, Jiang Miao developed the blood cane that makes artificial whole blood.

Once the problems of artificial organs and artificial blood are solved, and with the development of other medical technologies, the overall burden on the domestic medical system will be reduced by an order of magnitude. With the support of this technological dividend, the medical insurance fund can ensure the quality of medical care for all without increasing the burden on young people.

beep...

The cell phone beside me rang.

Jiang Miao looked at the number prompt and found that it was He Jintang, so he put down the report and slid the answer button: "Hello, Lao He, what's the matter?"

"I have something I wonder if you are interested in?"

"What can I do for you?" Jiang Miao asked with a smile.

He Jintang on the other end of the phone said bluntly: "Recently, the Asia Alliance plans to organize several medical volunteer teams to provide medical assistance in East Africa."

"Medical assistance?"

"Well, hasn't your company developed a lot of new medical technologies and medical products? Although human experiments can be conducted in China, the scale is definitely limited. You can go to East Africa to conduct human experiments in the name of medical aid."

Jiang Miao didn't think there was anything wrong with doing so.

For example, the famous Indian generic drugs. The reason why European and American medical companies acquiesced to Indian generic drugs was that they allowed European and American pharmaceutical companies to conduct human trials of drugs locally.

The reason why this type of generic drug is not produced in China is, on the one hand, due to patent issues, and on the other hand, due to concerns about the side effects of new drugs.

Many new drugs are often sold abroad for several years, or even more than ten years, and only considered for introduction into China after they are found to have no serious side effects. Those regions that directly allow new drugs from European and American pharmaceutical companies to be launched simultaneously may not be able to obtain new drugs first, but to put it bluntly, they are just guinea pigs in disguise.

"I will arrange with Hailufeng Company to send a medical volunteer team. We plan to experiment with artificial organs, artificial blood, new anesthetics, new antibiotics and other medical products in East Africa."

"Oh? Artificial blood? Can you even make artificial blood?"

"This is the same as the underlying technology of artificial organs, and it is not difficult to develop."

"Then I would like to congratulate your company in advance on adding a new best-selling product." There was a hint of smile in He Jintang's voice.

"Lend your blessings."

"I have another matter that I would like your company to cooperate with."

Jiang Miao replied directly: "As long as Hailufeng Company can complete it, I will do my best."

"It's not that difficult, it's just a little troublesome."

"whats the matter?"

“It’s a matter of travel for the medical volunteer team.”

"Isn't the East African region quite stable? There haven't been any major problems recently?" Jiang Miao was puzzled.

"It's not a big problem, but the local transportation is too backward. We can't just go there to build roads for a few medical aids."

Jiang Miao also reacted: "Old He, you guys want to borrow the passenger airship from Hailutong Express, right?"

"Yes, didn't you produce 11 helium-type passenger airships? Can you lend a few to the medical volunteer team?"

"Okay, I'll ask Hailutong Express to make an adjustment later to see how many ships we can squeeze out."

"Okay, in addition, this time the medical volunteer team is also equipped with 5 professional medical cruise ships. When the time comes, we will need your transport airships to resupply these medical cruise ships."

"No problem. I will have Hailutong Express do a special project for this order and ensure that there will be no slack."

"Then trouble you."

"You're welcome, it's easy."

The two chatted for a while and then hung up the phone.

Jiang Miao did not put down his phone, but called his internal affairs assistant Li Zixuan to come over and told him what had just happened.

This is indeed an opportunity.

In some domestic clinical trials, there are sometimes restrictions on how to conduct them. However, when conducting relevant clinical trials outside the Asian Union, there is no need to worry too much. Even if someone dies, it can be settled with money.

This is also a common method used by European and American pharmaceutical companies in backward areas. Through this method, they can quickly advance in human clinical trials.

Of course, European and American pharmaceutical companies sometimes even use various deceptive means to force ordinary people in their own countries who have no money or ordinary patients with illnesses to undergo clinical trials of various new drugs and technologies.

When it comes to treating people unfairly, European and American companies have a long history of this and always focus on treating everyone equally.

At least Hailufeng Hospital will not be so unscrupulous. Although it plans to use patients in East Africa for clinical trials this time, it will definitely not choose new drugs and new technologies with higher risks.

After Jiang Miao instructed Li Zixuan on some things, he continued his previous research work.

evening.

After a break in the wind and rain, the typhoon gradually transformed into a tropical cyclone after dissipating for most of the day.

As the outskirts of the typhoon's landing area, the raindrops in Jiexi County are much smaller.

A van carrying dinner drove into the base.

Jiang Miao ate a box lunch casually, then called Shuya to tell her that he would not return to Shanmei that night and would stay at the research base in Jiexi County overnight.

After dinner, he and Ah Hai came to a laboratory.

Passing through layers of gates.

The two came to a heavily guarded room where more than a dozen large breeding chambers were displayed.

Through the observation port of the incubator, you can see "people" inside. These are clones. However, unlike ordinary clones, these clones do not have brains, which means that they do not have thoughts, only physiological instincts.

In fact, if these brainless vegetative people lose the support of the life support system of the incubator, they will not be able to continue to survive. After all, they don’t even have the ability to think, let alone advanced skills such as eating, drinking, defecating and urinating.

“How much does it cost to cultivate?”

Ah Hai replied helplessly: "One is about 2.8 million, and the cultivation period is about half a year."

Jiang Miao did not find the price unacceptable: "The price is not bad. It is acceptable for some relatively difficult human experiments."

After all, there is no way to recruit subjects for human experiments on some highly difficult new technologies or potentially lethal drugs. This involves the life safety of the subjects and clearly violates the scientific ethics of human experiments.

That's why Jiang Miao secretly developed this kind of brainless plant clone to conduct some special human experiments.

For example, the artificial heart and artificial lungs that are to be developed next.

If artificial hearts and lungs are to be tested in clinical trials, it is difficult to find suitable subjects, and once problems arise in the clinical trials, it will be extremely difficult to rescue them.

At this time, brainless plant clones are very suitable experimental subjects, because they have bodies that are highly similar to normal humans, and there is no need to worry about experimental accidents.

Jiang Miao carefully observed the conditions of these experimental subjects through the identification panel and found that everything met his requirements. He turned around and ordered: "Activate a few more special breeding rooms. These sixteen experimental subjects are definitely not enough."

"No problem." Ah Hai nodded.

Jiang Miao then reminded: "By the way, remember to strengthen confidentiality. Although they are brainless clones, they are still highly similar to humans. If it is exposed, the keyboard warriors outside will complain again."

"Don't worry, boss. I will manage it well. Researchers who come into contact with this laboratory will be screened in advance." Ah Hai also knew the trouble of this kind of thing.

Although many biological and medical researchers do not think that these brainless clones are human beings, they are afraid that someone with a mental illness will expose this matter.

In terms of diversity, humans have created more than a hundred genders.

Among those scientific researchers, there must be people with different personalities.

Some people can accept this kind of thing.

Naturally, some people cannot accept this.

This is a great test for internal screening, as unacceptable researchers must be excluded before they come into contact with such confidential information, rather than waiting until everyone has access to the relevant information before trying to remedy the situation.

Jiang Miao had no choice. European and American forces could secretly conduct experiments on living people because they had the advantage of low human rights.

Within the Asian Union, high-risk experiments using living humans are definitely not allowed.

In order to avoid being overtaken by European and American forces, he could only create brainless clones to fill the gap in living experimental subjects.

(End of this chapter)